Details for New Drug Application (NDA): 216904
✉ Email this page to a colleague
The generic ingredient in DESMOPRESSIN ACETATE is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.
Summary for 216904
Tradename: | DESMOPRESSIN ACETATE |
Applicant: | Gland |
Ingredient: | desmopressin acetate |
Patents: | 0 |
Suppliers and Packaging for NDA: 216904
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DESMOPRESSIN ACETATE | desmopressin acetate | INJECTABLE;INJECTION | 216904 | ANDA | Fresenius Kabi USA, LLC | 65219-295 | 65219-295-10 | 1 VIAL, MULTI-DOSE in 1 CARTON (65219-295-10) / 10 mL in 1 VIAL, MULTI-DOSE |
DESMOPRESSIN ACETATE | desmopressin acetate | INJECTABLE;INJECTION | 216904 | ANDA | Gland Pharma Limited | 68083-549 | 68083-549-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (68083-549-01) / 10 mL in 1 VIAL, MULTI-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 0.004MG/ML | ||||
Approval Date: | Mar 20, 2023 | TE: | AP | RLD: | No |
Complete Access Available with Subscription